BioCentury
ARTICLE | Clinical News

Reolysin reovirus: Phase I

May 12, 2003 7:00 AM UTC

ONC said enrollment has resumed in a Phase I trial of a single intratumoral injection delivered with image-guided surgery in patients with refractory malignant glioma. Patients will be monitored for 6...